Lonza Group stock: CLSA raises target from CHF 759 to CHF 778

Published on 10/23/2026 at 16:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza targets 10.00-13.00 percent growth in the medium term. Lonza Group stock costs EUR 685.00 on October 23, 2026, 0.50 percent above the Xetra close.

Analyst target and growth outlook

CLSA raised its Lonza target from CHF 759.00 to CHF 778.00 on October 16, 2026.
Lonza targets 10.00-13.00 percent organic growth at constant exchange rates over the medium term.
Lonza Group stock costs EUR 685.00 at Lang & Schwarz on October 23, 2026 at 4:37 p.m. CEST, 0.50 percent above the Xetra close of October 22, 2026 at EUR 681.60, and 0.79 percent below the CHF 636.20 52-week high.

Pop-Art-Comic: Stilisierte Kapsel-Pille mit Halftone-Punkten und leerer Comic-Sprechblase — Lonza CH0013841017 Pop Art Comic Pille mit Halftone Punkten und leerer Comic Sprechblase, Illustration mit AI erstellt.

Lonza Group (ISIN CH0013841017) became the subject of a higher analyst valuation after Boerse Express reported that CLSA raised its Lonza target from CHF 759.00 to CHF 778.00 on October 16, 2026. That target is 23.26 percent above the SIX price of CHF 631.20 at 4:30 p.m. CEST on October 23, 2026. Lonza Group stock was trading at EUR 685.00 at Lang & Schwarz on October 23, 2026 at 4:37 p.m. CEST, 0.50 percent above the Xetra close of October 22, 2026 at EUR 681.60.

Growth targets set the backdrop

Lonza's medium-term plan calls for 10.00-13.00 percent organic growth at constant exchange rates. Its longer-term margin ambition is in the high-thirties percentage range, with the target raised by 400 to 500 basis points, according to MarketScreener on October 14, 2026.

The company kept its 2026 outlook at 11.00-12.00 percent sales growth at constant exchange rates and a 33.00-34.00 percent core EBITDA margin. Those figures describe the current-year plan, while the 10.00-13.00 percent range and high-thirties margin ambition extend further into the medium term.

Stock sits below its yearly high

On SIX, Lonza traded at CHF 631.20 at 4:30 p.m. CEST on October 23, 2026. Its 52-week range was CHF 454.60 to CHF 636.20, leaving the stock 0.79 percent below the high. The market capitalization was CHF 44.1 billion and volume was 59,522 shares at that time.

The euro quotation stood above the Xetra close by EUR 3.40, equivalent to 0.50 percent. The two-currency view matters because CLSA's target is stated in Swiss francs, while the German investor quote is stated in euros.

Upcoming dates and valuation signals

Lonza lists November 5, 2026 for the ZKB Swiss Equity Conference and November 17-18, 2026 for the Jefferies Healthcare Conference. The company also lists January 27, 2027 for its full-year 2026 results, giving investors a later date to test the confirmed outlook against reported numbers.

Analyst expectations meet execution

CLSA's CHF 778.00 target sits above Lonza's current SIX price, but the target remains an analyst assessment rather than a reported operating result. The numerical contrast is clear: the target implies 23.26 percent above the CHF 631.20 price, while the stock is only 0.79 percent below its 52-week high. That leaves the next valuation debate tied to whether the higher growth and margin ambitions translate into measured results.

Lonza price remains close to its high

Lonza Group stock was trading at EUR 685.00 at Lang & Schwarz on October 23, 2026 at 4:37 p.m. CEST, 0.50 percent above the Xetra close of October 22, 2026 at EUR 681.60. On SIX, the stock was at CHF 631.20 at 4:30 p.m. CEST on October 23, 2026.

The further course of trading is shown by the continuously updated real-time quote of Lonza Group stock.